Fatmanur İNCE ÖZGENEL, Zeliha TULEK, Şafak Meriç ÖZGENEL, Tuncer TEMEL

İnflamatuar Bağırsak Hastalığı Sıkıntı Ölçeği'nin Türkçe Geçerlik ve Güvenirliği

İnflamatuar bağırsak hastaları semptomların ve tedavinin yan etkilerinin günlük yaşam üzerindeki etkisi nedeniyle psikolojik sıkıntı yaşayabilirler. Bu çalışmanın amacı, İnflamatuar Bağırsak Hastalığı Sıkıntı Ölçeği'ni (İBH-SÖ) Türk diline uyarlamaktır. Bu metodolojik çalışma Türkiye’deki bir şehirde gastroenteroloji polikliniklerine başvuran 160 İBH hastası ile yürütülmüştür. İBH-SÖ'nün dilsel geçerliği için ileri-geri çeviri ve uzman görüşü yöntemleri kullanılmıştır. Güvenirlik analizi için Cronbach alfa ve test-tekrar test analizleri yapılmıştır. Yapı geçerliğini değerlendirmek için Kessler Psikolojik Sıkıntı Ölçeği (K10) ve Hastane Anksiyete ve Depresyon Ölçeği (HADS) kullanılmıştır. Ortalama İBH-SÖ puanı 54.64±40.99 (0-155) bulunmuştur. İç tutarlılık analizinde Cronbach alfa güvenilirlik katsayısı 0,963 olarak bulunmuş ve maddeler ile toplam puan arasındaki korelasyonlar 0,378 ile 0,816 arasında değişmiştir. Test-tekrar test puanları arasında iyi bir korelasyon (ICC) bulunmuştur (ICC, 0.99; %95 güven aralığı, .994-1.0). İBH-SÖ puanlarının K10 (r=0.467, p<.001) ve HADS (r=0.516, p<.001) ölçekleri ile orta ila güçlü korelasyon gösterdiği bulunmuştur. İBH-SÖ'nün Türkçe versiyonu, Türk popülasyonunda kullanım için psikometrik açıdan yeterli bir ölçek olarak bulunmuştur.

Anahtar Kelimeler:

inflamatuar bağırsak hastalığı, sıkıntı, inflamatuvar bağırsak hastalığı sıkıntı ölçeği, güvenirlik, geçerlik

Validity of The Turkish Version of The Inflammatory Bowel Disease Distress Scale

In inflammatory bowel disease, patients may experience psychological distress due to the impact of symptoms and side effects of treatment on daily life. The aim of this study is to adapt the Inflammatory Bowel Disease Distress Scale (IBD-DS) into the Turkish langugae. This methodological study was conducted with 160 IBD patients admitted to gastroenterology outpatient clinics in a city in Türkiye. For the linguistic validity of the IBD-DS, forward-backward-translation and expert opinion methods were used. For reliability analysis, Cronbach's alpha and test-retest analysis were performed. The Kessler Psychological Distress Scale (K10) and the Hospital Anxiety and Depression Scale (HADS) were used to assess construct validity. The mean IBD-DS score was 54.64±40.99 (0-155). Internal consistency analysis yielded a reliability coefficient of Cronbach's alpha of 0.963, and correlations between the items and the total score ranged from 0.378 to 0.816. Good intraclass correlation (ICC) was found between test-retest scores (ICC, 0.99; 95% confidence interval, .994-1.0). It was found that IBD-DS scores were moderately to strongly correlated with the K10 (r=0.467, p<.001) and HADS (r=0.516, p<.001) scales. The Turkish version of the IBD-DS has been found to be a psychometrically adequate scale for use in the Turkish population.

Keywords:

inflammatory bowel disease, distress, inflammatory bowel disease distress scale, reliability, validity,

PDF

___

1. Mikocka-Walus A, Massuger W, Knowles SR, Moore GT, Buckton S, Connell W, et al. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open. 2020;4:166–71.
2. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–78.
3. Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30.
4. Dibley L, Czuber-Dochan W, Woodward S, Wade T, Bassett P, Sturt J, et al. Development and psychometric properties of the ınflammatory bowel disease distress scale (IBD-DS): A New Tool to Measure Disease-Specific Distress. Inflamm Bowel Dis. 2018;24:2068–77.
5. Saeid Seyedian S, Nokhostin F, Dargahi Malamir M. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12:113–22.
6. Lewis K, Marrie RA, Bernstein CN, Graff LA, Patten SB, Sareen J, et al. The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with ınflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1674–80.
7. Emerson C, Fuller-Tyszkiewicz M, Orr R, Lyall K, Beswick L, Olive L, et al. Low subjective wellbeing ıs associated with psychological distress in people living with ınflammatory bowel disease. Dig Dis Sci. 2022 ;67:2059–66.
8. Gîlc-Blanariu G-E, Ștefnescu G, Trifan AV, Moscalu M, Dimofte M-G, Ștefnescu C, et al. Sleep ımpairment and psychological distress among patients with ınflammatory bowel disease beyond the obvious. J Clin Med. 2020;9:2304.
9. Kantidakis JD, Moulding R, Knowles SR. Psychological mediators of psychological distress and quality of life in inflammatory bowel disease. J Psychosom Res. 2021;149:110596.
10. Greywoode R, Ullman T, Keefer L. National prevalence of psychological distress and use of mental health care in ınflammatory bowel disease. Inflamm Bowel Dis. 2023;29:70–5.
11. Slonim-Nevo V, Sarid O, Friger M, Schwartz D, Sergienko R, Pereg A, et al. Effect of social support on psychological distress and disease activity in ınflammatory bowel disease patients. Inflamm Bowel Dis. 2018 ;24:1389–400.
12. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Heal [Internet]. 2005;8:94–104.
13. Harvey RF, Bradshaw JM. A simple index of crohn’s disease actıvıty. Lancet.1980;315(8167):514.
14. Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
16. Aydemir Ö. Hastane Anksiyete ve depresyon ölçeği Türkçe formunun geçerlilik ve güvenilirlik çalışması. Türk Psikiyatr Derg. 1997;8:280–7.
17. Altun Y, Özen M, Kuloğlu M. Turkish adaptation of Kessler Psychological Distress Scale: validity and reliability study. Anatol J Psychiatry. 2019;1.
18. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental ıllness in the general population. Arch Gen Psychiatry. 2003 Feb 1;60(2):184.
19. Berding A, Witte C, Gottschald M, Kaltz B, Weiland R, Gerlich C, et al. Beneficial effects of education on emotional distress, self-management, and coping in patients with ınflammatory bowel disease: A prospective randomized controlled study. Inflamm Intest Dis. 2016;1(4):182–90.
20. Gromisch ES, Neto LO, Sloan J, Tyry T, Foley FW. Using the multiple sclerosis resiliency scale to identify psychological distress in persons with multiple sclerosis. Mult Scler Relat Disord. 2021 Aug;53:103079.
21. Patella V, Pelaia C, Zunno R, Pelaia G. Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic. Respir Med. 2022 Aug;200:106916.
22. Tran L, Sharrad K, Kopsaftis Z, Stallman HM, Tai A, Spurrier N, et al. Pharmacological interventions for the treatment of psychological distress in patients with asthma: a systematic review and meta-analysis. J Asthma. 2021;58:759–69.
23. Bassi G, Gabrielli S, Donisi V, Carbone S, Forti S, Salcuni S. Assessment of psychological distress in adults with type 2 diabetes mellitus through technologies: Literature Review. J Med Internet Res. 2021;23:e17740.
24. Herschbach P, Britzelmeir I, Dinkel A, Giesler JM, Herkommer K, Nest A, et al. Distress in cancer patients: Who are the main groups at risk? Psychooncology. 2020;29:703–10.
25. Evans S, Olive L, Dober M, Knowles S, Fuller-Tyszkiewicz M, O E, et al. Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): Protocol for a feasibility trial of the ACT for IBD programme. BMJ Open. 2022 ;12:e060272.
26. Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M, et al. Impact of female gender in ınflammatory bowel diseases: A Narrative Review. J Pers Med. 2023;13:165.
27. Yan X, Qiao Y, Tong J, Mao R, Liang J, Lv C, et al. Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus. Health Qual Life Outcomes. 2020;18:241.
28. Leone D, Gilardi D, Corrò BE, Menichetti J, Vegni E, Correale C, et al. Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison between active and nonactive patients. Inflamm Bowel Dis. 2019;25:1399–407.
29. Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: A systematic review of the comorbidity of depression and anxiety with ınflammatory bowel diseases. Vol. 22, Inflammatory Bowel Diseases. 201. p. 752–62.
30. Zhang Y-Y, Li W, Sheng Y. The Chinese version of the revised diabetes distress scale for adults with type 2 diabetes: Translation and validation study. Int J Nurs Sci. 2022 Apr;9(2):243–51.
31. Toledo-Fernández A, Betancourt-Ocampo D, González-González A. Distress, depression, anxiety, and concerns and behaviors related to COVID-19 during the first two months of the pandemic: A longitudinal study in adult Mexicans. Behav Sci. 2021;11:76.